Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $20
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Lake Street analyst Brooks O'Neil maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from $50 to $20.
Lake Street analyst Brooks O'Neil maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from $50 to $20.